The effect of a single 4CMenB vaccine booster in young people more than ten years after infant immunisation: protocol of an exploratory immunogenicity study

BACKGROUND AND RATIONALE: The four-component capsular group B meningococcal vaccine (4CMenB) was introduced into the national immunisation schedule in the UK in September 2015 for infants in a 2 + 1 schedule at two, four and 12 months of age. A two-dose immunisation schedule for adolescents was also...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Kimberly, Ford, Karen, Craik, Rachel, Galal, Ushma, Rollier, Christine S., Pollard, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657159/
https://www.ncbi.nlm.nih.gov/pubmed/31340842
http://dx.doi.org/10.1186/s13063-019-3494-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657159/
https://www.ncbi.nlm.nih.gov/pubmed/31340842
http://dx.doi.org/10.1186/s13063-019-3494-1

Ejemplares similares